Ni Y - Search Results

1

Radiolabeled iodohypericin as tumor necrosis avid tracer: diagnostic and therapeutic potential.

Van de Putte M, Marysael T, Fonge H, Roskams T, Cona MM, Li J, Bormans G, Verbruggen A, Ni Y, de Witte PA. Van de Putte M, et al. Among authors: ni y. Int J Cancer. 2012 Jul 15;131(2):E129-37. doi: 10.1002/ijc.26492. Epub 2012 Jan 11. Int J Cancer. 2012. PMID: 22038886

2

Necrosis-avid contrast agents: introducing nonporphyrin species.

Ni Y, Cresens E, Adriaens P, Miao Y, Verbeke K, Dymarkowski S, Verbruggen A, Marchall G. Ni Y, et al. Acad Radiol. 2002 May;9 Suppl 1:S98-101. doi: 10.1016/s1076-6332(03)80409-9. Acad Radiol. 2002. PMID: 12019908 No abstract available.

3

Exploring multifunctional features of necrosis avid contrast agents.

Ni Y, Cresens E, Adriaens P, Dymarkowski S, Bogaert J, Zhang H, Bosmans H, Verbruggen A, Marchal G. Ni Y, et al. Acad Radiol. 2002 Aug;9 Suppl 2:S488-90. doi: 10.1016/s1076-6332(03)80272-6. Acad Radiol. 2002. PMID: 12188317 No abstract available.

4

Potentiation of photodynamic therapy with hypericin by mitomycin C in the radiation-induced fibrosarcoma-1 mouse tumor model.

Chen B, Ahmed B, Landuyt W, Ni Y, Gaspar R, Roskams T, de Witte PA. Chen B, et al. Among authors: ni y. Photochem Photobiol. 2003 Sep;78(3):278-82. doi: 10.1562/0031-8655(2003)078<0278:poptwh>2.0.co;2. Photochem Photobiol. 2003. PMID: 14556315

5

Synthesis, characterization, and pharmacokinetic evaluation of a potential MRI contrast agent containing two paramagnetic centers with albumin binding affinity.

Parac-Vogt TN, Kimpe K, Laurent S, Vander Elst L, Burtea C, Chen F, Muller RN, Ni Y, Verbruggen A, Binnemans K. Parac-Vogt TN, et al. Among authors: ni y. Chemistry. 2005 May 6;11(10):3077-86. doi: 10.1002/chem.200401207. Chemistry. 2005. PMID: 15776492

6

Necrosis avid contrast agents: functional similarity versus structural diversity.

Ni Y, Bormans G, Chen F, Verbruggen A, Marchal G. Ni Y, et al. Invest Radiol. 2005 Aug;40(8):526-35. doi: 10.1097/01.rli.0000171811.48991.5a. Invest Radiol. 2005. PMID: 16024991 Review.

7

Magnetic resonance imaging after radiofrequency ablation in a rodent model of liver tumor: tissue characterization using a novel necrosis-avid contrast agent.

Ni Y, Chen F, Mulier S, Sun X, Yu J, Landuyt W, Marchal G, Verbruggen A. Ni Y, et al. Eur Radiol. 2006 May;16(5):1031-40. doi: 10.1007/s00330-005-0094-0. Epub 2006 Jan 21. Eur Radiol. 2006. PMID: 16429271

8

First preclinical evaluation of mono-[123I]iodohypericin as a necrosis-avid tracer agent.

Ni Y, Huyghe D, Verbeke K, de Witte PA, Nuyts J, Mortelmans L, Chen F, Marchal G, Verbruggen AM, Bormans GM. Ni Y, et al. Eur J Nucl Med Mol Imaging. 2006 May;33(5):595-601. doi: 10.1007/s00259-005-0013-2. Epub 2006 Feb 1. Eur J Nucl Med Mol Imaging. 2006. PMID: 16450141

9

Synthesis and preliminary evaluation of mono-[123I]iodohypericin monocarboxylic acid as a necrosis avid imaging agent.

Fonge H, Jin L, Wang H, Ni Y, Bormans G, Verbruggen A. Fonge H, et al. Among authors: ni y. Bioorg Med Chem Lett. 2007 Jul 15;17(14):4001-5. doi: 10.1016/j.bmcl.2007.04.083. Epub 2007 Apr 30. Bioorg Med Chem Lett. 2007. PMID: 17507220

10

Evaluation of tumor affinity of mono-[(123)I]iodohypericin and mono-[(123)I]iodoprotohypericin in a mouse model with a RIF-1 tumor.

Fonge H, Van de Putte M, Huyghe D, Bormans G, Ni Y, de Witte P, Verbruggen A. Fonge H, et al. Among authors: ni y. Contrast Media Mol Imaging. 2007 May-Jun;2(3):113-9. doi: 10.1002/cmmi.136. Contrast Media Mol Imaging. 2007. PMID: 17546702 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,255 results

Search Page

Filters